Recent developments in primary open angle glaucoma and ocular hypertension

MeReC Bulletin

Volumn 13, Issue 5, 2003, Pages 17-20

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; EYE DROPS; LATANOPROST; LATANOPROST PLUS TIMOLOL MALEATE; LONG ACTING DRUG; NYOGEL; PILOCARPINE; PROSTAGLANDIN DERIVATIVE; PROSTAMIDE; TIMOLOL; TIMOLOL LA; TOPICAL AGENT; TRAVOPROST; UNCLASSIFIED DRUG;

ASTHMA; BLINDNESS; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG INDICATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG USE; EYE IRRITATION; EYE SURGERY; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; OPTIC DISK; OPTIC NERVE ATROPHY; PATIENT EDUCATION; PATIENT MONITORING; PREVALENCE; REGISTRATION; REVIEW; RISK FACTOR; TRABECULOTOMY; TREATMENT INDICATION; UNITED KINGDOM; VISION TEST; VISUAL DISORDER; VISUAL FIELD;

EID: 0037274267     PISSN: 14655659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Shah R, Wormald R. Glaucoma. In: Clinical Evidence. 8th ed. Editor: Jones G. London: BMJ Publishing Group; 2002.
2. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996;80:389-93.
3. The Royal College of Ophthalmologists. Glaucoma management. Focus 1998;(6).
4. Guidelines for the management of ocular hypertension and primary open angle glaucoma. London: Royal College of Ophthalmologists; 1997.
5. Understanding glaucoma. London: The Royal College of Ophthalmologists/International Glaucoma Association/RNIB; 2001.
6. Evans J, Rooney C, Ashwood F, et al. Blindness and partial sight in England and Wales: April 1990-March 1991. Health Trends 1996;28:5-12.
7. Sowerby Centre for Health Informatics at Newcastle. PRODIGY clinical recommendation: glaucoma. December 2002. Available from: URL: http://www.prodigy.nhs.uk. Accessed 23/3/03.
8. Membrey WL, Poinoosawmy DP, Bunce C, et al. Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation. Br J Ophthalmol 2000;84:1154-8.
9. Khaw FT, Cordiero MIT. Towards better treatment of glaucoma. BMJ 2000;320:1619-20.
10. Prescription cost analysis data. London: Department of Health; 1998. Available from: URL: http://www.doh.gov.uk/stats/pca1998.pdf
11. Prescription cost analysis data. London: Department of Health; 2001. Available from: URL: http://www.doh.gov.uk/stats/pca2001.pdf
12. Gandolfi SA, Cimino L. Effect on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. Ophthalmol 2003;110:609-14.
13. Zhang WY, Li Wan Po A, Dual HS, et al. Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. Br J Ophthalmol 2001;85:983-90.
14. Netland PA, Landry T, Sullivan EK, et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001; 132:472-84.
15. O'Donoghue EP and the UK and Ireland latanoprost study group. A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Br J Ophthalmol 2000; 84:579-82.
16. Whitcup SM, Cantor LB, VanDenburgh, et al. A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension. Br J Ophthalmol 2003;87:57-62.
17. Noecker RS, Monte DS, Choplin NT, et al. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol 2003;135:55-63.
18. LeBlanc RP for the brimonidine study group. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Ophthalmol 1998;105:1960-7.
19. March WF, Ochsner KI and the brinzolamide long-term therapy study group. The long-term safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2000;129:136-43.
20. Department of Health. Drug Tariff (March edition). London: The Stationery Office; 2003.
21. Monthly Index of Medical Specialities. March edition. London: Haymarket Medical Publications; 2003.
22. Whittaker KW, Gillow JT, Cunliffe IA. Is the role of trabeculectomy in glaucoma management changing? Eye 2001;15:449-52.
23. Bateman DN, Clark R, Azuara-Blanco A, et al. The effects of new topical treatments on management of glaucoma in Scotland: an examination of ophthalmological health care. Br J Ophthalmol 2002; 86: 551-4.